In the United States in 2015, approximately 73,870 invasive melanoma cases will be diagnosed and of those, 9,940 will die from the disease. Treatment at later stages of the disease is associated with metastasis to internal organs and ultimately, death. These data underscore the critical significance of early detection of melanoma. Our ongoing R01 randomized controlled trial (RCT) demonstrated preliminary evidence for a melanoma survivor and skin check partner-assisted skin self-examination (SSE) training program resulting in regular and accurate SSEs relative to patients and partners receiving treatment as usual care. However, four critical questions remain unanswered: 1) Whether these patients will retain the knowledge/skills in real-world conditions following the conclusion of the RCT; 2) Whether they will continue to engage in reliable SSE behaviors with their skin check partners; 3) Whether they will retain the high level of accuracy of the SSEs with their skin check partners; and 4) Do they differ from patients who receive training while under the customary care of their own dermatologists? The proposed continuation builds on our NCI funded studies of Stage I to IIA melanoma patients by examining the influence of SSE training on early detection behaviors in real- world conditions. Our existing treatment condition patients' (TRT1) SSE early detection behaviors will be compared to three groups: 1) Participants who receive the tablet- intervention accessed via the web while under the customary care of their own dermatologists; (TRT2); 2) active-controls - control participants from the RCT who were repeatedly surveyed and seen by study-physicians every 4 mo. over the past two years who are also returning to the care of their own dermatologists (C1); and 3) assessment- only controls - control participants to be recruited for the proposed study (C2). The current proposal will contribute critical information to the scientific literature on the impact of early detection of melanomas using SSEs and will be the first to test the sustainability and long-term impact of an efficacious SSE intervention for early detection targeting melanoma survivors in real-world settings. Specifically, the aims of the study will examine: 1) the long-term efficacy of SSE training on knowledge, performance, and accuracy under real-world conditions; and 2) whether patient-partner relationship qualities and age moderate the relationship between the conditions (treatment/controls) and SSE outcomes (retention of SSE knowledge, performance, and accuracy).

Public Health Relevance

In the United States in 2015, approximately 73,870 invasive melanoma cases will be diagnosed and of those, 9,940 will die from the disease. Treatment at later stages of the disease is associated with metastasis to internal organs and ultimately death; therefore, the early detection of melanoma is critical. Our previous work has demonstrated evidence for a melanoma survivor and partner skin self-examination (SSE) training program and the current proposal will contribute critical information to the scientific literature on the impac of early detection of melanomas using SSEs and will be the first to test the SSE intervention in real-world settings.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
2R01CA154908-06A1
Application #
9105012
Study Section
Community-Level Health Promotion Study Section (CLHP)
Program Officer
Perna, Frank
Project Start
2011-05-13
Project End
2020-03-31
Budget Start
2016-04-01
Budget End
2017-03-31
Support Year
6
Fiscal Year
2016
Total Cost
Indirect Cost
Name
Northwestern University at Chicago
Department
Dermatology
Type
Schools of Medicine
DUNS #
005436803
City
Chicago
State
IL
Country
United States
Zip Code
60611
Mannam, Harshitha; Choi, Andrew; Jacob, Saya et al. (2018) Assessment of the Diameter of Pigmented Skin Lesions With and Without a Ruler. JAMA Dermatol 154:221-223
Xu, S; Stump, T K; Jain, J et al. (2018) Variation in daily ultraviolet radiation exposure and sun protection behaviours of melanoma survivors: an observational single-arm pilot study with a wearable sensor. Br J Dermatol :
Johnson, Mariah M; Leachman, Sancy A; Aspinwall, Lisa G et al. (2017) Skin cancer screening: recommendations for data-driven screening guidelines and a review of the US Preventive Services Task Force controversy. Melanoma Manag 4:13-37
Rzepecki, A K; Jain, N; Ali, Y et al. (2017) Promoting early detection of melanoma during the mammography experience. Int J Womens Dermatol 3:195-200
Flood, Kelsey S; Martin, Gary J; Robinson, June K (2017) Uniform Nomenclature to Describe Clinical Features of Pigmented Lesions. JAMA Dermatol 153:973-975
Robinson, June K; Penedo, Frank J; Hay, Jennifer L et al. (2017) Recognizing Latinos' range of skin pigment and phototypes to enhance skin cancer prevention. Pigment Cell Melanoma Res 30:488-492
Robinson, June K; Nodal, Mercedes; Chavez, Leonid et al. (2017) Enhancing the Relevance of Skin Self-examination for Latinos. JAMA Dermatol 153:717-718
Robinson, June K; Hultgren, Brittney; Mallett, Kimberly et al. (2017) Self-confidence and Embarrassment About Partner-Assisted Skin Self-examination for Melanoma. JAMA Dermatol 153:342-344
Robinson, June K; Halpern, Allan C (2016) Cost-effective Melanoma Screening. JAMA Dermatol 152:19-21
Hultgren, Brittney A; Turrisi, Rob; Mallett, Kimberly A et al. (2016) Influence of Quality of Relationship Between Patient With Melanoma and Partner on Partner-Assisted Skin Examination Education: A Randomized Clinical Trial. JAMA Dermatol 152:184-90

Showing the most recent 10 out of 18 publications